Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcella Prete

Showing results (61-70 of 72) with videos related to

Pageof 8
Sort By:
Frontiers in Immunology|July 6, 2026
Ophthalmic involvement in VEXAS syndrome and its influence on mortality: insights from the international AIDA network registryJurgen Sota, Andrea Hinojosa-Azaola, Eduardo Martín-Nares, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 11, 2020
Early Disease and Low Baseline Damage as Predictors of Response to Belimumab in Patients With Systemic Lupus Erythematosus in a Real-Life SettingMariele Gatto, Francesca Saccon, Margherita Zen, et al.
Journal of Personalized Medicine|April 28, 2023
Early and Late Response and Glucocorticoid-Sparing Effect of Belimumab in Patients with Systemic Lupus Erythematosus with Joint and Skin Manifestations: Results from the Belimumab in Real Life Setting Study-Joint and Skin (BeRLiSS-JS)Margherita Zen, Mariele Gatto, Roberto Depascale, et al.
Autoimmunity Reviews|July 15, 2017
International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease managementRoberto Giacomelli, Antonella Afeltra, Alessia Alunno, et al.
Frontiers in Immunology|March 30, 2026
Recurrent fever and association with severe organ involvement, mortality and treatment outcomes in VEXAS syndrome: data from the AIDA NetworkValeria Caggiano, Jessica Sbalchiero, Micol Frassi, et al.
RMD Open|November 21, 2023
Derivation and validation of four patient clusters in Still's disease, results from GIRRCS AOSD-study group and AIDA Network Still Disease RegistryPiero Ruscitti, Francesco Masedu, Antonio Vitale, et al.
Seminars in Arthritis and Rheumatism|January 31, 2026
VEXAS syndrome and cancer: Insights about a possible "Tip of the Iceberg". Ambidirectional data from the international AIDA network registriesFrancesco Gavioli, Valeria Caggiano, Jessica Sbalchiero, et al.
Frontiers in Medicine|January 28, 2026
Clinical and laboratory markers to distinguish VEXAS from Schnitzler's syndrome: data from the AIDA network registriesValeria Caggiano, Jessica Sbalchiero, Micol Frassi, et al.
Autoimmunity Reviews|July 28, 2024
Tailoring the treatment of inflammatory rheumatic diseases by a better stratification and characterization of the clinical patient heterogeneity. Findings from a systematic literature review and experts' consensusPiero Ruscitti, Yannick Allanore, Chiara Baldini, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 19, 2024
The Systemic Score May Identify Life-Threatening Evolution in Still Disease: Data from the GIRRCS AOSD-Study Group and the AIDA Network Still Disease RegistryPiero Ruscitti, Francesco Masedu, Antonio Vitale, et al.
Pageof 8

Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
Frontiers in Immunology|July 6, 2026
Ophthalmic involvement in VEXAS syndrome and its influence on mortality: insights from the international AIDA network registryJurgen Sota, Andrea Hinojosa-Azaola, Eduardo Martín-Nares, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 11, 2020
Early Disease and Low Baseline Damage as Predictors of Response to Belimumab in Patients With Systemic Lupus Erythematosus in a Real-Life SettingMariele Gatto, Francesca Saccon, Margherita Zen, et al.
Journal of Personalized Medicine|April 28, 2023
Early and Late Response and Glucocorticoid-Sparing Effect of Belimumab in Patients with Systemic Lupus Erythematosus with Joint and Skin Manifestations: Results from the Belimumab in Real Life Setting Study-Joint and Skin (BeRLiSS-JS)Margherita Zen, Mariele Gatto, Roberto Depascale, et al.
Autoimmunity Reviews|July 15, 2017
International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease managementRoberto Giacomelli, Antonella Afeltra, Alessia Alunno, et al.
Frontiers in Immunology|March 30, 2026
Recurrent fever and association with severe organ involvement, mortality and treatment outcomes in VEXAS syndrome: data from the AIDA NetworkValeria Caggiano, Jessica Sbalchiero, Micol Frassi, et al.
RMD Open|November 21, 2023
Derivation and validation of four patient clusters in Still's disease, results from GIRRCS AOSD-study group and AIDA Network Still Disease RegistryPiero Ruscitti, Francesco Masedu, Antonio Vitale, et al.
Seminars in Arthritis and Rheumatism|January 31, 2026
VEXAS syndrome and cancer: Insights about a possible "Tip of the Iceberg". Ambidirectional data from the international AIDA network registriesFrancesco Gavioli, Valeria Caggiano, Jessica Sbalchiero, et al.
Frontiers in Medicine|January 28, 2026
Clinical and laboratory markers to distinguish VEXAS from Schnitzler's syndrome: data from the AIDA network registriesValeria Caggiano, Jessica Sbalchiero, Micol Frassi, et al.
Autoimmunity Reviews|July 28, 2024
Tailoring the treatment of inflammatory rheumatic diseases by a better stratification and characterization of the clinical patient heterogeneity. Findings from a systematic literature review and experts' consensusPiero Ruscitti, Yannick Allanore, Chiara Baldini, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 19, 2024
The Systemic Score May Identify Life-Threatening Evolution in Still Disease: Data from the GIRRCS AOSD-Study Group and the AIDA Network Still Disease RegistryPiero Ruscitti, Francesco Masedu, Antonio Vitale, et al.
Pageof 8